News & Events

From the category archives: Omega News

News

UK Public Sector Contract disclosure

Omega's contract with DHSC to provide manufacturing capacity for COVID-19 lateral flow antigen tests estimated at £374 million.

Read the full RNS here

Contract with Screen4 for COVID-19 antibody laboratory-based testing service

Omega announces that it has signed a contract with Screen4 Ltd to provide a testing service using the Mologic ELISA antibody test for COVID-19 from our in-house testing laboratory in Littleport, Cambridgeshire. This follows the launch of the COVID-19 antibody testing service, as announced on 26 January 2021.

Read the full RNS here

Directorate Change

We are pleased to announce the appointment of Dr Simon Douglas as independent Non-Executive Chairman. Simon has been appointed to the Board with immediate effect and has also become a member of both the Audit Committee and the Remuneration Committee.

Read the full RNS here

UK Government manufacturing contract

Omega announces that it has agreed a contract with the Department of Health and Social Care to provide manufacturing capacity for COVID-19 lateral flow antigen tests, as part of the UK Government’s well-publicised target of producing two million lateral flow tests per day.

Read the full RNS here

Launch of COVID-19 antibody laboratory-based testing service

We are pleased to announce that we have launched the Mologic ELISA antibody test for COVID-19 through our in-house testing laboratory service in Littleport, Cambridgeshire.

Read the full RNS here

Update re AbC-19™ Rapid Test

Omega notes today’s update from Abingdon Health regarding the AbC-19™ Rapid Test and welcomes confirmation that they continue to work constructively with the Medicines and Healthcare products Regulatory Agency to try to enable approval for home use and self-test of the AbC-19™ Rapid Test in the UK.

Read the full RNS here

Mologic CE Mark Rapid Antigen Test

Omega welcomes the news that Mologic Ltd has received CE Mark for its professional-use COVID-19 Rapid Antigen Test.

In June this year, Omega signed a material transfer agreement with Mologic providing access to raw materials and know-how to manufacture their lateral flow antigen test. The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs.

Read the full RNS here

Chinese approval for self-test use of Food Detective® test

The National Medical Products Administration (“NMPA”), formerly the China Food and Drug Administration, has approved Omega’s Food Detective® test for self-test use in China.

Read the full RNS here

UK-RTC contract for the Supply of Goods

Omega has signed a contract with Abingdon Health, the UK Rapid Test Consortium (UK-RTC) lead, which sets out the terms of the supply of goods from UK-RTC members to Abingdon Health. This follows the UK Government’s initial order of one million COVID-19 lateral flow antibody tests (AbC-19™ Rapid test).

The UK-RTC contract formalises the agreement among UK-RTC members and Abingdon Health, in order for Abingdon Health to supply AbC-19™ Rapid tests to the Department of Health and Social Care (DHSC). 

Read the full RNS here

UK Government contract for UK-Rapid Test Consortium

A press release was issued today by the UK Rapid Test Consortium on the UK Government’s first order for one million COVID-19 lateral flow antibody tests (AbC-19™ Rapid test).

This first order is part of the UK Government’s plans to roll-out COVID-19 surveillance studies to help build a picture of how the virus has spread across the country.

Read the full RNS here

Pages: Previous123NextReturn Top